From BioLtd Balance Sheet Health
Financial Health criteria checks 3/6
From BioLtd has a total shareholder equity of ₩75.2B and total debt of ₩18.4B, which brings its debt-to-equity ratio to 24.5%. Its total assets and total liabilities are ₩97.4B and ₩22.2B respectively.
Key information
24.5%
Debt to equity ratio
₩18.40b
Debt
Interest coverage ratio | n/a |
Cash | ₩6.44b |
Equity | ₩75.17b |
Total liabilities | ₩22.19b |
Total assets | ₩97.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: A377220's short term assets (₩37.7B) exceed its short term liabilities (₩21.9B).
Long Term Liabilities: A377220's short term assets (₩37.7B) exceed its long term liabilities (₩288.1M).
Debt to Equity History and Analysis
Debt Level: A377220's net debt to equity ratio (15.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if A377220's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: A377220's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if A377220's interest payments on its debt are well covered by EBIT.